MedPath

Randomised controlled trial comparing the effects of oxytocin 5 units IV bolus vs oxytocin 5 units IV infusion on cardiac output during caesarean section - Effect on cardiac output of oxytocin bolus vs. infusio

Phase 1
Conditions
The drug is given routinely to women during caesarean section to help the womb contract after their baby has been delivered. This helps reduce the risk of bleeding after surgery. For this trial, the drug will be given to these women as routine, but the mode of administration will vary between an I.V. bolus or an I.V infusion to assess the effects of administration upon heart rate and blood pressure.
MedDRA version: 9.1 Level: LLT Classification code 10006924 Term: Caesarean section
Registration Number
EUCTR2007-002949-20-GB
Lead Sponsor
iverpool Women's NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
32
Inclusion Criteria

All patients who are due to undergo elective caesarean section under spinal anaesthesia at more than 37 weeks gestation; ASA grade 1 or 2; age 18 or over.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Conversion to general anaesthetic; placenta praevia; diabetes mellitus; pregnancy induced hypertension; chronic hypertension; patients requiring peri-operative therapeutic anti-coagulant therapy; pre operative anaemia; liver disease; chronic renal failure; history of anaphylaxis to oxytocin.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath